Answer Summary

Members expressed deep appreciation for an ambassador's successful advocacy to add WHO classification groups beyond PAH to the platform,... Read more

Members expressed deep appreciation for an ambassador's successful advocacy to add WHO classification groups beyond PAH to the platform, making it easier for people with different types of pulmonary hypertension to connect with others who share their specific diagnosis and treatment paths. Several members shared their own diagnostic journeys, including lengthy wait times for testing due to insurance requirements, the challenge of being reclassified between WHO groups, and the complexity of determining classifications when conditions like sleep apnea, interstitial lung disease, or mixed connective tissue disease are involved. A recurring theme was gratitude for this community improvement and the importance of knowing your WHO group classification, keeping copies of test results, and connecting with others who understand your specific experience.